Anatomy and Cell Biology

Korean Association of Anatomists (대한해부학회)
권호 표지
DOI QR코드

DOI QR Code

Transient lysosomal activation is essential for p75 nerve growth factor receptor expression in myelinated Schwann cells during Wallerian degeneration

  • Jung, Jun-Yang (Department of Physiology, Mitochondria Hub Research Center, College of Medicine, Dong-A University) ;
  • Cai, Wenting (Department of Physiology, Mitochondria Hub Research Center, College of Medicine, Dong-A University) ;
  • Jang, So-Young (Department of Physiology, Mitochondria Hub Research Center, College of Medicine, Dong-A University) ;
  • Shin, Yoon-Kyoung (Department of Physiology, Mitochondria Hub Research Center, College of Medicine, Dong-A University) ;
  • Suh, Duk-Joon (Department of Physiology, Mitochondria Hub Research Center, College of Medicine, Dong-A University) ;
  • Kim, Jong-Kuk (Department of Neurology, Mitochondria Hub Research Center, College of Medicine, Dong-A University) ;
  • Park, Hwan-Tae (Department of Physiology, Mitochondria Hub Research Center, College of Medicine, Dong-A University)
  • Published : 2011.03.31
⟨ Previous Next ⟩

Abstract

Myelinated Schwann cells in the peripheral nervous system express the p75 nerve growth factor receptor (p75NGFR) as a consequence of Schwann cell dedifferentiation during Wallerian degeneration. p75NGFR has been implicated in the remyelination of regenerating nerves. Although many studies have shown various mechanisms underlying Schwann cell dedifferentiation, the molecular mechanism contributing to the re-expression of p75NGFR in differentiated Schwann cells is largely unknown. In the present study, we found that lysosomes were transiently activated in Schwann cells after nerve injury and that the inhibition of lysosomal activation by chloroquine or lysosomal acidification inhibitors prevented p75NGFR expression at the mRNA transcriptional level in an ex vivo Wallerian degeneration model. Lysosomal acidification inhibitors suppressed demyelination, but not axonal degeneration, thereby suggesting that demyelination mediated by lysosomes may be an important signal for inducing p75NGFR expression. Tumor necrosis factor-$\alpha$ (TNF-$\alpha$) has been suggested to be involved in regulating p75NGFR expression in Schwann cells. In this study, we found that removing TNF-$\alpha$ in vivo did not significantly suppress the induction of both lysosomes and p75NGFR. Thus, these findings suggest that lysosomal activation is tightly correlated with the induction of p75NGFR in demyelinating Schwann cells during Wallerian degeneration.

Keywords

References

  1. Martini R, Fischer S, Lopez-Vales R, David S. Interactions between Schwann cells and macrophages in injury and inherited demyelinating disease. Glia 2008;56:1566-77. https://doi.org/10.1002/glia.20766
  2. Reichert F, Saada A, Rotshenker S. Peripheral nerve injury induces Schwann cells to express two macrophage phenotypes: phagocytosis and the galactose-specific lectin MAC-2. J Neurosci 1994;14(5 Pt 2):3231-45.
  3. Hallpike JF, Adams CW. Proteolysis and myelin breakdown: a review of recent histochemical and biochemical studies. Histochem J 1969;1:559-78. https://doi.org/10.1007/BF01012862
  4. Hallpike JF, Adams CW, Bayliss OB. Histochemistry of myelin. IX. Neutral and acid proteinases in early Wallerian degeneration. Histochem J 1970;2:209-18. https://doi.org/10.1007/BF01003470
  5. Weller RO, Mellick RS. Acid phosphatase and lysosome activity in diphtheritic neuropathy and Wallerian degeneration. Br J Exp Pathol 1966;47:425-34.
  6. Lee HK, Shin YK, Jung J, Seo SY, Baek SY, Park HT. Proteasome inhibition suppresses Schwann cell dedifferentiation in vitro and in vivo. Glia 2009;57:1825-34. https://doi.org/10.1002/glia.20894
  7. Meyer M, Matsuoka I, Wetmore C, Olson L, Thoenen H. Enhanced synthesis of brain-derived neurotrophic factor in the lesioned peripheral nerve: different mechanisms are responsible for the regulation of BDNF and NGF mRNA. J Cell Biol 1992;119:45-54. https://doi.org/10.1083/jcb.119.1.45
  8. Zhang JY, Luo XG, Xian CJ, Liu ZH, Zhou XF. Endogenous BDNF is required for myelination and regeneration of injured sciatic nerve in rodents. Eur J Neurosci 2000;12:4171-80.
  9. Hu X, He W, Diaconu C, Tang X, Kidd GJ, Macklin WB, Trapp BD, Yan R. Genetic deletion of BACE1 in mice affects remyelination of sciatic nerves. FASEB J 2008;22:2970-80. https://doi.org/10.1096/fj.08-106666
  10. Zhang L, Ma Z, Smith GM, Wen X, Pressman Y, Wood PM, Xu XM. GDNF-enhanced axonal regeneration and myelination following spinal cord injury is mediated by primary effects on neurons. Glia 2009;57:1178-91. https://doi.org/10.1002/glia.20840
  11. Xiao J, Kilpatrick TJ, Murray SS. The role of neurotrophins in the regulation of myelin development. Neurosignals 2009;17:265-76. https://doi.org/10.1159/000231893
  12. Heumann R, Korsching S, Bandtlow C, Thoenen H. Changes of nerve growth factor synthesis in nonneuronal cells in response to sciatic nerve transection. J Cell Biol 1987;104:1623-31. https://doi.org/10.1083/jcb.104.6.1623
  13. Taniuchi M, Clark HB, Schweitzer JB, Johnson EM Jr. Expression of nerve growth factor receptors by Schwann cells of axotomized peripheral nerves: ultrastructural location, suppression by axonal contact, and binding properties. J Neurosci 1988;8:664-81.
  14. Song XY, Zhou FH, Zhong JH, Wu LL, Zhou XF. Knockout of p75(NTR) impairs re-myelination of injured sciatic nerve in mice. J Neurochem 2006;96:833-42. https://doi.org/10.1111/j.1471-4159.2005.03564.x
  15. Tomita K, Kubo T, Matsuda K, Fujiwara T, Yano K, Winograd JM, Tohyama M, Hosokawa K. The neurotrophin receptor p75NTR in Schwann cells is implicated in remyelination and motor recovery after peripheral nerve injury. Glia 2007;55:1199-208. https://doi.org/10.1002/glia.20533
  16. Bolin LM, Shooter EM. Neurons regulate Schwann cell genes by diffusible molecules. J Cell Biol 1993;123:237-43. https://doi.org/10.1083/jcb.123.1.237
  17. Stoll G, Jung S, Jander S, van der Meide P, Hartung HP. Tumor necrosis factor-alpha in immune-mediated demyelination and Wallerian degeneration of the rat peripheral nervous system. J Neuroimmunol 1993;45:175-82. https://doi.org/10.1016/0165-5728(93)90178-2
  18. Schneider-Schaulies J, Kirchhoff F, Archelos J, Schachner M. Down-regulation of myelin-associated glycoprotein on Schwann cells by interferon-gamma and tumor necrosis factor-alpha affects neurite outgrowth. Neuron 1991;7:995-1005. https://doi.org/10.1016/0896-6273(91)90344-Y
  19. Bonetti B, Valdo P, Stegagno C, Tanel R, Zanusso GL, Ramarli D, Fiorini E, Turazzi S, Carner M, Moretto G. Tumor necrosis factor alpha and human Schwann cells: signalling and phenotype modulation without cell death. J Neuropathol Exp Neurol 2000;59:74-84.
  20. Lisak RP, Bealmear B, Benjamins JA, Skoff AM. Interferon-gamma, tumor necrosis factor-alpha, and transforming growth factor-beta inhibit cyclic AMP-induced Schwann cell differentiation. Glia 2001;36:354-63. https://doi.org/10.1002/glia.1122
  21. Lee HK, Seo IA, Park HK, Park YM, Ahn KJ, Yoo YH, Park HT. Nidogen is a prosurvival and promigratory factor for adult Schwann cells. J Neurochem 2007;102:686-98. https://doi.org/10.1111/j.1471-4159.2007.04580.x
  22. Lee HK, Seo IA, Suh DJ, Hong JI, Yoo YH, Park HT. Interleukin-6 is required for the early induction of glial fibrillary acidic protein in Schwann cells during Wallerian degeneration. J Neurochem 2009;108:776-86. https://doi.org/10.1111/j.1471-4159.2008.05826.x
  23. Michihara A, Toda K, Kubo T, Fujiwara Y, Akasaki K, Tsuji H. Disruptive effect of chloroquine on lysosomes in cultured rat hepatocytes. Biol Pharm Bull 2005;28:947-51. https://doi.org/10.1248/bpb.28.947
  24. Boyle K, Azari MF, Cheema SS, Petratos S. TNFalpha mediates Schwann cell death by upregulating p75NTR expression without sustained activation of NFkappaB. Neurobiol Dis 2005;20:412-27. https://doi.org/10.1016/j.nbd.2005.03.022
  25. Jessen KR, Mirsky R. Negative regulation of myelination: relevance for development, injury, and demyelinating disease. Glia 2008;56:1552-65. https://doi.org/10.1002/glia.20761
  26. Vroemen M, Weidner N. Purification of Schwann cells by selection of p75 low affinity nerve growth factor receptor expressing cells from adult peripheral nerve. J Neurosci Methods 2003;124:135-43. https://doi.org/10.1016/S0165-0270(02)00382-5
  27. Nakashima S, Hiraku Y, Tada-Oikawa S, Hishita T, Gabazza EC, Tamaki S, Imoto I, Adachi Y, Kawanishi S. Vacuolar H+-ATPase inhibitor induces apoptosis via lysosomal dysfunction in the human gastric cancer cell line MKN-1. J Biochem 2003;134:359-64. https://doi.org/10.1093/jb/mvg153
  28. Ishidoh K, Kominami E. Processing and activation of lysosomal proteinases. Biol Chem 2002;383:1827-31.
  29. Stoll G, Li CY, Trapp BD, Griffin JW. Expression of NGF-receptors during immune-mediated and lysolecithin-induced demyelination of the peripheral nervous system. J Neurocytol 1993;22:1022-9. https://doi.org/10.1007/BF01235746
  30. Toews AD, Griffiths IR, Kyriakides E, Goodrum JF, Eckermann CE, Morell P, Thomson CE. Primary demyelination induced by exposure to tellurium alters Schwann cell gene expression: a model for intracellular targeting of NGF receptor. J Neurosci 1992;12:3676-87.
  31. Hanemann CO, Gabreels-Fasten AA, Muller HW, Stoll G. Low affinity NGF receptor expression in CMT1A nerve biopsies of different disease stages. Brain 1996;119(Pt 5):1461-9. https://doi.org/10.1093/brain/119.5.1461

Cited by

  1. Adenosine 5′-Triphosphate (ATP) Inhibits Schwann Cell Demyelination During Wallerian Degeneration vol.34, pp.3, 2011, https://doi.org/10.1007/s10571-013-0020-y
  2. ATP Release through Lysosomal Exocytosis from Peripheral Nerves: The Effect of Lysosomal Exocytosis on Peripheral Nerve Degeneration and Regeneration after Nerve Injury vol.2014, pp.None, 2011, https://doi.org/10.1155/2014/936891
  3. Schwann cell autophagy, myelinophagy, initiates myelin clearance from injured nerves vol.210, pp.1, 2011, https://doi.org/10.1083/jcb.201503019
  4. Specific Marker Expression and Cell State of Schwann Cells during Culture In Vitro vol.10, pp.4, 2011, https://doi.org/10.1371/journal.pone.0123278
  5. A novel effect of ethyl pyruvate in Schwann cell de-differentiation and proliferation during Wallerian degeneration vol.19, pp.4, 2011, https://doi.org/10.1080/19768354.2015.1053520
  6. Physiological Importance of Hydrogen Sulfide: Emerging Potent Neuroprotector and Neuromodulator vol.2016, pp.None, 2011, https://doi.org/10.1155/2016/9049782
  7. Schwann cell dedifferentiation‐associated demyelination leads to exocytotic myelin clearance in inflammatory segmental demyelination vol.65, pp.11, 2011, https://doi.org/10.1002/glia.23200
  8. Taxanes and platinum derivatives impair Schwann cells via distinct mechanisms vol.7, pp.None, 2011, https://doi.org/10.1038/s41598-017-05784-1
  9. The conceptual introduction of the “demyelinating Schwann cell” in peripheral demyelinating neuropathies vol.67, pp.4, 2019, https://doi.org/10.1002/glia.23509
  10. The histone deacetylase class I, II inhibitor trichostatin A delays peripheral neurodegeneration vol.50, pp.2, 2011, https://doi.org/10.1007/s10735-019-09815-1
  11. The natural plant flavonoid apigenin is a strong antioxidant that effectively delays peripheral neurodegenerative processes vol.94, pp.4, 2011, https://doi.org/10.1007/s12565-019-00486-2
  12. Schwann cell p75 neurotrophin receptor modulates small fiber degeneration in diabetic neuropathy vol.68, pp.12, 2020, https://doi.org/10.1002/glia.23881
  13. Mesenchymal Stem Cells Derived from Wharton’s Jelly Can Differentiate into Schwann Cell-Like Cells and Promote Peripheral Nerve Regeneration in Acellular Nerve Grafts vol.18, pp.3, 2021, https://doi.org/10.1007/s13770-020-00329-6